GlycoScientific Email Format

Biotechnology ResearchGeorgia, United States2-10 Employees

GlycoScientific operates in the biotechnology research sector, focusing on tools that support glycobiology—the study of sugars, saccharides, and glycans involved in cellular communication, signaling, and disease processes. Its work addresses the need to identify, characterize, and quantify these glycans, which are linked to conditions such as cancer, diabetes, heart disease, Alzheimer’s, and autoimmune disorders. The company serves researchers and institutions seeking deeper insights into glycan-related biology and disease mechanisms, offering products that facilitate analysis in this emerging field. Based in Athens, Georgia, GlycoScientific is a small- to mid-sized biotechnology firm. A notable recent development is the launch of iGlycoMab, a monoclonal antibody with labeled glycans, announced in May 2015.

Sign up for free to view info

Company overview Employee directory